Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Pierre Fabre Laboratories and Iktos Announce an Integrated AI-Driven Drug Discovery Collaboration in Oncology 2026-01-09 15:00
Ribo Life Science (06938.HK) Successfully Lists on the Main Board of the Hong Kong Stock Exchange 2026-01-09 13:07
Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference 2026-01-08 19:00
Ark Biopharmaceutical Receives China Marketing Authorization for Aizhida for the Treatment of ADHD 2026-01-08 17:58
Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report 2026-01-06 16:21
Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform 2026-01-06 12:03
Everest Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference 2026-01-06 07:58
Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA 2026-01-05 20:00
Sisram Medical Reports Completion of NIFDC Testing for DAXXIFY in China 2026-01-05 17:36
Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC 2026-01-05 17:29
Ascletis Announces U.S. FDA IND Clearance for 13-Week Phase II Study of Its Oral Small Molecule GLP-1, ASC30, in Participants with Diabetes 2026-01-05 08:10
Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange 2025-12-31 08:55
Alphamab Oncology Announces IND Application for a Phase II Clinical Study of HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 as First-line Treatment of Advanced Cervical Cancer was Officially Accepted by CDE 2025-12-29 13:52
Hakka Medicine Goes Global: Jiaying Pharmaceutical Launches the Global Promotion Plan for Hakka Medicine in Hong Kong 2025-12-24 10:00
TraceLink Wins 2025 Merit Award -- Recognized for Healthcare Innovation for the Third Consecutive Year 2025-12-22 23:00
Guardant Health Japan receives regulatory approval of Guardant360® CDx liquid biopsy as companion diagnostic for imlunestrant in metastatic or recurrent breast cancer previously treated with endocrine therapy 2025-12-22 16:00
Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH® CTC enumeration to guide treatment decisions in a specific metastatic breast cancer subtype 2025-12-22 16:00
Fosun International Honored with TVB's Highest Accolade, "Outstanding ESG Award" 2025-12-22 09:00
Wong To Yick Unveils Revitalised Official Website 2025-12-22 09:00
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions 2025-12-22 05:40
1 2 3 4 5 282